Significance of basal IGF-I, IGFBP-3 and IGFBP-2 measurements in the diagnostics of short stature in children

Hormone Research

Volumn 54, Issue 2, 2000, Pages 60-68

  Ranke, M B ^a   Schweizer, R ^a   Elmlinger, M W ^a   Weber, K ^a   Binder, G ^a   Schwarze, C P ^a   Wollmann, H A ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Diagnostics; Growth hormone deficiency; Idiopathic short stature; IGF I; IGFBP 2; IGFBP 3; IUGR; Turner syndrome

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RELIABILITY; SCHOOL CHILD; SHORT STATURE; TURNER SYNDROME;

ADOLESCENT; ADULT; ANTHROPOMETRY; BODY HEIGHT; CHILD; CHILD, PRESCHOOL; DIAGNOSTIC TESTS, ROUTINE; HUMAN GROWTH HORMONE; HUMANS; INFANT; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; REFERENCE VALUES;

EID: 0034469899     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053233     Document Type: Article

References (48)

1. Towards a consensus on the definition of idiopathic short stature
2. Longitudinal follow-up of growth in children born small for gestational age
3. Consensus on how to measure growth hormone in serum
4. An endocrinologist's approach to the growth hormone-insulin-like growth factor axis
5. The role of insulin-like growth factors in the diagnosis of growth hormone deficiency
6. Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development
7. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: The relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation
8. An update of the Swedish reference standards for weight, length and head circumference at birth for given gestational age (1977-1981)
9. Cross sectional stature and weight reference curves for the UK, 1990
10. A correction to the TW2 RUS-based tables for predicting adult height
11. Growth hormone stimulation tests
12. Analysis of 24-hour growth hormone profiles in healthy boys and girls of normal stature: Relation to puberty
13. Radioimmunoassays for IGFs and IGFBPs
14. A specific radioimmu-noassay for the growth hormone (GH)-dependent somatomedin-binding protein: Its use for diagnosis of GH deficiency
15. Insulin-like growth factor binding protein 2 is differentially expressed in leukaemic B- and T-cell lines
16. Magnetic resonance images of 91 children with different causes of short stature: Pituitary size reflects growth hormone secretion
17. Height of normal pituitary gland as a function of age evaluated by magnetic resonance imaging in children
18. IGF-1 and IGFBP-3 screening for disorders of growth hormone secretion
19. Diagnostic controversy: The diagnosis of childhood growth hormone deficiency revisited
20. Growth hormone insensitivity syndromes: A preliminary report on changes in insulin-like growth factors and their binding proteins during treatment with recombinant insulin-like growth factor I
21. Physiology of insulin-like growth factor binding protein-3 and its role in disorders of the growth hormone axis
22. Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion
23. Plasma free insulin-like growth factor I concentrations in growth hormone deficiency in children and adolescents
24. Normative data for insulin-like growth factors (IGFs), IGF-binding proteins, and growth hormone-binding protein in a healthy Spanish pediatric population: Age- and sex-related changes
25. Biochemical tests in the diagnosis of childhood growth hormone deficiency
26. IGFBP-3: Age related normal data and correlation with IGF-I
27. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children
28. Serum somatomedin-C in hypopituitarism and in other disorders of growth
29. Insulin-like growth factor binding proteins (IGFBPs) with special reference to IGFBP-3
30. Somatomedin A levels in serum from healthy children and from children with growth hormone deficiency or delayed puberty
31. Insulin-like growth factor-I as a reflection of body composition, nutrition, and puberty in sixth and seventh grade girls
32. Insulin-like growth factors I and II in evaluation of growth retardation
33. Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay
34. Radioimmunoassay for insulin-like growth factorI: Solutions to some potential problems and pitfalls
35. The RIA for IGFBP-2 in man - A meagre catch?
36. High molecular weight insulin-like growth factor binding protein complex: Purification and properties of the acid-labile subunit from human serum
37. Use of insulin-like growth factor-binding protein 3 for the evaluation of growth disorders
38. Diagnostic markers of permanent idiopathic growth hormone deficiency
39. Is IGF binding protein-3 assessment helpful for the diagnosis of GH deficiency?
40. Serum levels of IGFBP-3: Usefulness in diagnosis of GH deficiency and relationship to measurements of GH secretion in children
41. Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 concentrations compared to stimulated and night growth hormone in the evaluation of short children: A clinical research center study
42. Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency
43. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions
44. Clinical studies of IGFBP-2 by radioimmunoassay
45. Failure of IGF-I and IGFBP-3 to diagnose growth hormone insufficiency
46. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age
47. Artificial neural networks in pathology and medical laboratories